Conceptualising the impact of genetic testing on cancer disparities in the USA

Testing for germ-line mutations offers a predictive tool of hereditary cancer risk with the promise of future benefits to the US healthcare system and its consumers. Based on the few studies on genetic testing for cancer, awareness and uptake appear to be lower among racial/ethnic minorities. The sources of variation need to be understood for ethical reasons and for more successful technology diffusion in the broader population. We conceptualise...